HomeRVMD • NASDAQ
add
Revolution Medicines Inc
Previous close
$39.05
Day range
$38.38 - $39.31
Year range
$15.44 - $40.21
Market cap
6.63B USD
Avg Volume
1.29M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 742.00K | -95.16% |
Operating expense | 18.64M | 70.89% |
Net income | -161.54M | -185.87% |
Net profit margin | -21.77K | -5,806.26% |
Earnings per share | -1.14 | -81.75% |
EBITDA | -153.17M | -152.80% |
Effective tax rate | -0.21% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.85B | 187.31% |
Total assets | 2.06B | 153.93% |
Total liabilities | 235.51M | 85.82% |
Total equity | 1.83B | — |
Shares outstanding | 164.69M | — |
Price to book | 3.52 | — |
Return on assets | -25.36% | — |
Return on capital | -27.44% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -161.54M | -185.87% |
Cash from operations | -120.56M | -95.12% |
Cash from investing | -380.40M | -5,254.76% |
Cash from financing | 839.35M | 1,534.16% |
Net change in cash | 338.39M | 2,030.45% |
Free cash flow | -29.13M | 20.66% |
About
Founded
2014
Headquarters
Website
Employees
378